# A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

> **NCT04162015** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 22 (actual)

## Conditions studied

- Malignant Pleural Mesothelioma

## Interventions

- **DRUG:** Nivolumab
- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin or Carboplatin

## Key facts

- **NCT ID:** NCT04162015
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-12
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04162015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04162015, "A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04162015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*